Levosimendan Form I, C<sub>14</sub>H<sub>12</sub>N<sub>6</sub>O. [PDF]
Salazar JK +3 more
europepmc +1 more source
The quantitative haemodynamic effect of levosimendan, dobutamine, and milrinone in heart failure patients: a meta-analysis. [PDF]
Nuzzi V +10 more
europepmc +1 more source
Premature stopping of LEIA-HF: protecting trial participants while preserving clinical knowledge. [PDF]
Grand J, Olesen ASO, Jakobsen JC.
europepmc +1 more source
Preoperative Administration of Levosimendan to Prevent Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery: A Retrospective Study. [PDF]
Boillat L +7 more
europepmc +1 more source
Efficacy and safety of levosimendan in acute heart failure patients with different body mass index: a multicenter, retrospective, observational real-world study. [PDF]
Liu W, Yang L, Chen Z, Wu Y, Lai H.
europepmc +1 more source
Milrinone and levosimendan improve microvascular perfusion in septic rats: a randomized, placebo-controlled trial. [PDF]
Marcus C +12 more
europepmc +1 more source
Effect of levosimendan treatment in cardiac surgery: a network meta-analysis of randomized controlled trials. [PDF]
Zhu B, Zhao W, Li Y.
europepmc +1 more source
The potential effect of calcium sensitizer in pulmonary hypertension post-coronavirus disease-19 infection in presumptive familial dilated cardiomyopathy: a case report. [PDF]
Andryan DP +2 more
europepmc +1 more source
The possible impact of levosimendan infusions on clinical course of heart failure: the results of the LEIA-HF study. [PDF]
Kazimierczyk E +21 more
europepmc +1 more source
Comparative safety and efficacy of levosimendan versus dobutamine in acute heart failure: a systematic review, meta-analysis, and meta-regression. [PDF]
Raja A +17 more
europepmc +1 more source

